Grant-backed platform · device and algorithm development · Earlier iron insight

ZAWADI™

The gift of knowing earlier.

Zawadi is a non-invasive platform in development to estimate erythrocyte zinc protoporphyrin, an indicator associated with iron-restricted erythropoiesis. The concept combines photoacoustic sensing with an on-device result.

Zawadi portable optical reader for non-invasive erythrocyte zinc protoporphyrin assessment.

PORTABLE OPTICS

Problem to potential
The problem

Grant-backed platform · device and algorithm development

A woman should not have to become anaemic before her iron deficiency is seen.

Iron can disappear quietly—through pregnancy, heavy periods, recovery and everyday life. Zawadi is being developed to help care teams see iron-restricted erythropoiesis earlier, without making every first question begin with a needle.

Our response
Context
Evidence
Design
Solution
Built with purpose

For antenatal care teams, primary care programmes and diagnostic partners.

A non-invasive signal, brought closer to care.

Zawadi is a non-invasive platform in development to estimate erythrocyte zinc protoporphyrin, an indicator associated with iron-restricted erythropoiesis. The concept combines photoacoustic sensing with an on-device result.

Potential impact

What progress could unlock.

These are the outcomes guiding development. Product claims will follow the evidence generated at the appropriate stage.

01

Create an earlier window for nutrition or treatment support

02

Extend screening to settings with constrained laboratory access

03

Build calibration evidence across diverse skin tones

Evidence behind this work

Emotion opens the door. Evidence keeps us honest.

These sources support the clinical category or scientific rationale. They do not establish product-specific safety, efficacy or regulatory approval for Zawadi.

Development pathway

Where Zawadi stands today.

Current stage: Prototype development

Prototype build, calibration and clinical feasibility work